In this study, after NOX2 knockdown in ESCC cells, both mRNA and protein levels of BTG2 significantly increased, indicating that targeting NOX2 may inhibit ESCC cell proliferation by upregulating BTG2 expression. The gene discussed is BTG2; the disease is esophageal squamous cell carcinoma.